Yixintang Pharmaceutical Group Co (SZSE:002727) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co Change In Receivables?

Yixintang Pharmaceutical Group Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Yixintang Pharmaceutical Group Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Yixintang Pharmaceutical Group Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥407 Mil. It means Yixintang Pharmaceutical Group Co's Accounts Receivable declined by ¥407 Mil from Dec. 2022 to Dec. 2023 .

Yixintang Pharmaceutical Group Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,964 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Yixintang Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 35.14.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Yixintang Pharmaceutical Group Co's liquidation value for the three months ended in Mar. 2024 was ¥-2,052 Mil.

Yixintang Pharmaceutical Group Co Change In Receivables Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co Change In Receivables Chart

Yixintang Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

40.75

-279.41

-739.71

-765.83

407.33

Yixintang Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Yixintang Pharmaceutical Group Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Yixintang Pharmaceutical Group Co (SZSE:002727) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Yixintang Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1963.865	/	5099.518	*	91
=	35.14

2. In Ben Graham's calculation of liquidation value, Yixintang Pharmaceutical Group Co's accounts receivable are only considered to be worth 75% of book value:

Yixintang Pharmaceutical Group Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3905.883	-	9413.788	+	0.75 * 1963.865	+	0.5 * 3966.085
=	-2,052

Yixintang Pharmaceutical Group Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500

Website

http://www.hx8886.com

Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.

Executives

Zhang Yong	Directors, executives
Xiao Dong Lei	Executives
Liu Qiong	Director
Ruan Hong Xian	Directors, executives
Guo Chun Li	Director
Ruan Guo Wei	Directors, executives
Li Zheng Hong	Directors, executives
Zhao Biao	Directors, executives
Tian Jun	Directors, Directors, and Executives
Xu Ke Yi	Director
Luo Yong Bin	Executives
Zhou Hong Yun	Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines